The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Nov. 11, 11:02 PM

Slide #2. SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) 1 for 50 Reverse Split

Announced: 11/6/2019
Stock Split: 1 for 50
Record Date: 11/7/2019
Pay Date: 11/8/2019
SLS Optionable?: No

SELLAS Life Sciences Group is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapeutics for a range of cancer indications. Co.'s product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Co.'s primary product candidate, GPS is a cancer immunotherapeutic agent, that targets the Wilms tumor 1, protein, which is present in various cancer types. NPS is a cancer immunotherapy targeting the human epidermal growth factor receptor expressing cancers. GALE-301 and GALE 302 are cancer immunotherapies that target the E39 peptide derived from the folate binding protein.
SLS Detailed Information Page & Split History »

Company Name: 
SELLAS Life Sciences Group Inc
Website: 
www.sellaslife.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding SLS: 
3
Total Market Value Held by ETFs: 
$42.64M
Total Market Capitalization: 
$31.00M
% of Market Cap. Held by ETFs: 
137.54%

Open the SLS Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.00 out of 4)
34th percentile
(ranked lower than approx. 66% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.